2022 ICD-10-CM Code R87.616
Satisfactory cervical smear but lacking transformation zone
Code Classification
R87.616 is a billable diagnosis code used to specify a medical diagnosis of satisfactory cervical smear but lacking transformation zone. The code R87.616 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code R87.616 might also be used to specify conditions or terms like satisfactory for evaluation but limited by absence of an endocervical/transformation zone component from a patient with a cervix.
The code R87.616 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.
The code is commonly used in ob/gyn medical specialties to specify clinical concepts such as abnormal female genital cytology.
According to ICD-10-CM guidelines this code should not to be used as a principal diagnosis code when a related definitive diagnosis has been established.
Entries in the Index to Diseases and Injuries with references to R87.616
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code R87.616 are found in the index:
- - Abnormal, abnormality, abnormalities - See Also: Anomaly;
Code Edits
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
- Diagnoses for females only - The Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, these edits apply to FEMALES only .
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Satisfactory for evaluation but limited by absence of an endocervical/transformation zone component from a patient with a cervix
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code R87.616 is grouped in the following groups for version MS-DRG V39.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2021 through 09/30/2022.
MS-DRG | MS-DRG Title | MCD | Relative Weight |
---|---|---|---|
742 | UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC | 13 | 1.717 |
743 | UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC | 13 | 1.1323 |
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert R87.616 to ICD-9 Code
- 795.07 - Sat cerv smr-no trnsfrm
Information for Patients
Cervical Cancer Screening
The cervix is the lower part of the uterus, the place where a baby grows during pregnancy. Cancer screening is looking for cancer before you have any symptoms. Cancer found early may be easier to treat.
Cervical cancer screening is usually part of a woman's health checkup. There are two types of tests: the Pap test and the HPV test. For both, the doctor or nurse collects cells from the surface of the cervix. With the Pap test, the lab checks the sample for cancer cells or abnormal cells that could become cancer later. With the HPV test, the lab checks for HPV infection. HPV is a virus that spreads through sexual contact. It can sometimes lead to cancer. If your screening tests are abnormal, your doctor may do more tests, such as a biopsy.
Cervical cancer screening has risks. The results can sometimes be wrong, and you may have unnecessary follow-up tests. There are also benefits. Screening has been shown to decrease the number of deaths from cervical cancer. You and your doctor should discuss your risk for cervical cancer, the pros and cons of the screening tests, at what age to start being screened, and how often to be screened.
[Learn More in MedlinePlus]
Related Codes
ICD Code | Description | Valid for Submission |
---|---|---|
R87 | Abnormal findings in specimens from female genital organs | NON-BILLABLE CODE |
R87.0 | Abnormal level of enzymes in specimens from female genital organs | BILLABLE CODE |
R87.1 | Abnormal level of hormones in specimens from female genital organs | BILLABLE CODE |
R87.2 | Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs | BILLABLE CODE |
R87.3 | Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs | BILLABLE CODE |
R87.4 | Abnormal immunological findings in specimens from female genital organs | BILLABLE CODE |
R87.5 | Abnormal microbiological findings in specimens from female genital organs | BILLABLE CODE |
R87.6 | Abnormal cytological findings in specimens from female genital organs | NON-BILLABLE CODE |
R87.61 | Abnormal cytological findings in specimens from cervix uteri | NON-BILLABLE CODE |
R87.610 | Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US) | BILLABLE CODE |
R87.611 | Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H) | BILLABLE CODE |
R87.612 | Low grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL) | BILLABLE CODE |
R87.613 | High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL) | BILLABLE CODE |
R87.614 | Cytologic evidence of malignancy on smear of cervix | BILLABLE CODE |
R87.615 | Unsatisfactory cytologic smear of cervix | BILLABLE CODE |
R87.618 | Other abnormal cytological findings on specimens from cervix uteri | BILLABLE CODE |
R87.619 | Unspecified abnormal cytological findings in specimens from cervix uteri | BILLABLE CODE |
R87.62 | Abnormal cytological findings in specimens from vagina | NON-BILLABLE CODE |
R87.620 | Atypical squamous cells of undetermined significance on cytologic smear of vagina (ASC-US) | BILLABLE CODE |
R87.621 | Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H) | BILLABLE CODE |
R87.622 | Low grade squamous intraepithelial lesion on cytologic smear of vagina (LGSIL) | BILLABLE CODE |
R87.623 | High grade squamous intraepithelial lesion on cytologic smear of vagina (HGSIL) | BILLABLE CODE |
R87.624 | Cytologic evidence of malignancy on smear of vagina | BILLABLE CODE |
R87.625 | Unsatisfactory cytologic smear of vagina | BILLABLE CODE |
R87.628 | Other abnormal cytological findings on specimens from vagina | BILLABLE CODE |
R87.629 | Unspecified abnormal cytological findings in specimens from vagina | BILLABLE CODE |
R87.69 | Abnormal cytological findings in specimens from other female genital organs | BILLABLE CODE |
R87.7 | Abnormal histological findings in specimens from female genital organs | BILLABLE CODE |
R87.8 | Other abnormal findings in specimens from female genital organs | NON-BILLABLE CODE |
R87.81 | High risk human papillomavirus (HPV) DNA test positive from female genital organs | NON-BILLABLE CODE |
R87.810 | Cervical high risk human papillomavirus (HPV) DNA test positive | BILLABLE CODE |
R87.811 | Vaginal high risk human papillomavirus (HPV) DNA test positive | BILLABLE CODE |
R87.82 | Low risk human papillomavirus (HPV) DNA test positive from female genital organs | NON-BILLABLE CODE |
R87.820 | Cervical low risk human papillomavirus (HPV) DNA test positive | BILLABLE CODE |
R87.821 | Vaginal low risk human papillomavirus (HPV) DNA test positive | BILLABLE CODE |
R87.89 | Other abnormal findings in specimens from female genital organs | BILLABLE CODE |
R87.9 | Unspecified abnormal finding in specimens from female genital organs | BILLABLE CODE |
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)